Search company, investor...

Predict your next investment

3x5 Partners company logo
Venture Capital
3x5partners.com

Investments

20

Portfolio Exits

3

Funds

1

About 3x5 Partners

3x5 Partners is a growth-oriented venture capital firm that primarily invests in innovations in life sciences and resource-driven sectors.

Headquarters Location

2540 NE Martin Luther King Jr Blvd

Portland, Oregon, 97212,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest 3x5 Partners News

09:00 ET AMERICAN CENTURY TO EXPAND INTO $10T PRIVATE MARKETS

Jun 29, 2023

News provided by Share this article Share this article Transaction will bring 3x5 Partners investment team to American Century to lead its entry into private markets KANSAS CITY, Mo., June 29, 2023 /PRNewswire/ -- American Century Investments®, a more than $200 billion* global asset manager, announced its planned entrance into the rapidly growing private markets with the impact venture capital team from 3x5 Partners joining American Century to lead its new private impact investment capabilities. Nicholas Walrod, Tony Arnerich, and Joe Biller, managing partners of 3x5 Partners, will lead the new private impact investment team and report to Victor Zhang, chief investment officer for American Century. The new team has more than 10 years' experience in private impact investments and will bring that experience to American Century. "We are always thinking about how we can best serve clients and looking for innovative solutions to their investment needs. In adding the 3x5 Partners team, we will grow our capabilities for our clients across the globe who are increasingly allocating to private markets, allowing us to be a more complete asset manager for our clients," said Jonathan Thomas, president and CEO of American Century. American Century expects its new private market investment capabilities to most interest its global institutional clients, as well as clients of high-net-worth financial professionals. The venture capital team coming from 3x5 Partners expects to benefit from American Century's distribution, investment, and operations infrastructure while continuing to operate out of Portland, Oregon. The transaction is scheduled to be completed in the third quarter, subject to closing conditions being met. "For more than 60 years, we have expanded our investment capabilities to offer clients solutions that help build their optimism and trust in their financial futures - from honing actively managed funds to our most recent growth and success in ETFs. And we have expanded who we serve - from individual investors to institutional investors and financial advisors. Expanding into private markets will be an exciting progression of our investment capabilities as we help our clients reach their financial goals," said Zhang. 3x5 Partners' history of performance Founded in 2011, 3x5 Partners has been seeking out companies that are delivering advancements in energy, food, water, shelter, health care, sanitation, and climate and environmental sustainability. The team has experience managing, individually or jointly, more than $500 million in the health care and climate solutions sectors. "Our commitment to delivering returns for clients while doing good is part of the strong alignment of purpose with American Century. American Century's impact on global health makes it a natural and inspiring fit for us to continue our work," said Walrod. Beyond its integration of financially material, sustainability-related factors into many of its investment processes in order to help deliver better long-term, risk-adjusted returns for its clients, American Century has made an impact on global health since 2000, when its founders bestowed an equity stake in the firm to the Stowers Institute for Medical Research. Since then, the Stowers Institute has received nearly $2 billion from this unique ownership structure. RBC Capital Markets provided strategic advice in this transaction. About American Century Investments American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting breakthrough medical research. Founded in 1958, American Century Investments' 1,400 employees serve financial professionals, institutions, corporations and individual investors from offices in New York; London; Frankfurt; Hong Kong; Sydney; Santa Clara, Calif.; and Kansas City, Mo. Jonathan S. Thomas is president and chief executive officer, and Victor Zhang serves as chief investment officer. Delivering investment results to clients enables American Century Investments to distribute over 40% of its earnings to the Stowers Institute for Medical Research, a 500-person, nonprofit basic biomedical research organization. The Institute owns more than 40% of American Century Investments and has received earnings of nearly $2 billion since 2000. For more information about American Century Investments, visit www.americancentury.com . *Assets under supervision as of 5/31/23. ©2023 American Century Proprietary Holdings, Inc. All rights reserved Many of American Century's investment strategies incorporate the consideration of environmental, social, and/or governance (ESG) factors into their investment processes in addition to traditional financial analysis. However, when doing so, the portfolio managers may not consider ESG factors with respect to every investment decision and, even when such factors are considered, they may conclude that other attributes of an investment outweigh ESG considerations when making decisions for the portfolio. The consideration of ESG factors may limit the investment opportunities available to a portfolio, and the portfolio may perform differently than those that do not incorporate ESG considerations. ESG data used by the portfolio managers often lacks standardization, consistency, and transparency, and for certain companies such data may not be available, complete, or accurate. Contact:          Susan Waldron

3x5 Partners Investments

20 Investments

3x5 Partners has made 20 investments. Their latest investment was in Bonum Therapeutics as part of their Series A on November 11, 2022.

CBI Logo

3x5 Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/15/2022

Series A

Bonum Therapeutics

$93M

No

11

8/23/2022

Series C

Fervo Energy

$138M

No

4

7/28/2022

Seed VC

EnZinc

$4.5M

Yes

1

4/4/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/3/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/15/2022

8/23/2022

7/28/2022

4/4/2022

2/3/2022

Round

Series A

Series C

Seed VC

Series A

Series B

Company

Bonum Therapeutics

Fervo Energy

EnZinc

Subscribe to see more

Subscribe to see more

Amount

$93M

$138M

$4.5M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

11

4

1

10

10

3x5 Partners Portfolio Exits

3 Portfolio Exits

3x5 Partners has 3 portfolio exits. Their latest portfolio exit was Good Therapeutics on September 07, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/7/2022

Acquired

$99M

14

4/28/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

11/14/2018

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/7/2022

4/28/2021

11/14/2018

Exit

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

14

10

10

3x5 Partners Fund History

1 Fund History

3x5 Partners has 1 fund, including 3x5 Partners Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/24/2020

3x5 Partners Fund III

$46.4M

3

Closing Date

9/24/2020

Fund

3x5 Partners Fund III

Fund Type

Status

Amount

$46.4M

Sources

3

3x5 Partners Team

5 Team Members

3x5 Partners has 5 team members, including current Founder, Managing Director, Nicholas Walrod.

Name

Work History

Title

Status

Nicholas Walrod

Arnerich Massena & Associates

Founder, Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Nicholas Walrod

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Arnerich Massena & Associates

Title

Founder, Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.